(Q44029779)

29 November 2017

title

Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

29 November 2017

main subject

1 reference

Ralph W Kuncl

1

1 reference

29 November 2017

Masako M Bilak

2

1 reference

29 November 2017

Stephan R Bilak

3

1 reference

29 November 2017

Andrea M Corse

4

1 reference

29 November 2017

Walter Royal

5

1 reference

29 November 2017

S Patricia Becerra

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Journal of Neurochemistry

29 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

volume

81

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

178-184

1 reference

Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons: comparison with GDNF and persephin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Epidermal growth factor in human cerebrospinal fluid: reduced levels in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in normal human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Neurotrophic factors and neuromuscular disease: I. General comments, the neurotrophin family, and neuropoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Neurofilament phosphorylation is enhanced in cultured chick spinal cord neurons exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Location and secretion of brain angiotensinogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Alterations in serum thrombospondin in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00813.X

10.1046/J.1471-4159.2002.00813.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference